Our team continues to support you during this phase with realistic check-ins and honest conversations
[8] [20] Beyond nausea, patients commonly experience a constellation of gastrointestinal symptoms including: Vomiting (reported in 24% of semaglutide users) Diarrhea (affecting 30% of patients) Constipation (occurring in 24% of users) Abdominal pain or discomfort (experienced by 20% of patients) Bloating and excessive gas Acid reflux or heartburn Decreased appetite (which, while therapeutic, can feel uncomfortable) The severity of these symptoms typically ranges from mild to moderate, and most patients do not discontinue treatment due to nausea alone
Many have to completely abstain
These peptides work through similar mechanisms, and combining them creates redundancy rather than synergy while potentially increasing side effects
Severe gastrointestinal symptoms : Persistent nausea, vomiting, or diarrhoea lasting more than a few days, which may impair levothyroxine absorption
Commitment to Research, Safety, and Education With Ozempic As the global manufacturer of Ozempic and Wegovy , Novo Nordisk places patient safety and education at the center of its mission